Welcome Guest
Home » Reports

Therapeutic Vaccines Market


Publication Date : November 2017

Therapeutic vaccines are being developed for various indications ranging from oncology to infectious diseases and neurology. Some specific disorders that the developers are focusing on include HIV, alzheimer’s, lung cancer, breast cancer and brain tumours. Dendreon Corporation’s Provenge became the first cancer therapeutic vaccine to receive FDA approval in April 2010. In addition, there are few more products, with limited launch in specific regions. The industry sees therapeutic vaccines as the future of vaccination, but the still awaits more high profile approvals. Our report will look at the rich pipeline, forecasting the performance of some key marketed and pipeline products.

Click here to know more

Upcoming Titles [ View all ]

Copyright © Roots Analysis. All Rights Reserved.
website security